RAD001 and Lenalidomide in the Treatment of Subjects With Relapsed and Relapsed/Refractory Multiple Myeloma

NCT00729638 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
28
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Massachusetts General Hospital

Collaborators